Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings Statistics

Total Valuation

ASBP has a market cap or net worth of $17.91 million. The enterprise value is $26.02 million.

Market Cap	17.91M
Enterprise Value	26.02M

Important Dates

The next estimated earnings date is Monday, November 24, 2025, before market open.

Earnings Date	Nov 24, 2025
Ex-Dividend Date	n/a

Share Statistics

ASBP has 49.53 million shares outstanding. The number of shares has decreased by -88.83% in one year.

Current Share Class	49.53M
Shares Outstanding	49.53M
Shares Change (YoY)	-88.83%
Shares Change (QoQ)	+30.20%
Owned by Insiders (%)	26.12%
Owned by Institutions (%)	5.16%
Float	33.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.39

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-64.24%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	32.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ASBP has paid $1,013 in taxes.

Income Tax	1,013
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.85% in the last 52 weeks. The beta is 0.67, so ASBP's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-96.85%
50-Day Moving Average	0.41
200-Day Moving Average	1.72
Relative Strength Index (RSI)	48.91
Average Volume (20 Days)	2,937,121

Short Selling Information

The latest short interest is 1.80 million, so 3.63% of the outstanding shares have been sold short.

Short Interest	1.80M
Short Previous Month	808,837
Short % of Shares Out	3.63%
Short % of Float	5.33%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.11M
Pretax Income	-18.90M
Net Income	-18.90M
EBITDA	n/a
EBIT	-3.11M
Earnings Per Share (EPS)	-$0.38

Balance Sheet

The company has $206,233 in cash and $8.47 million in debt, giving a net cash position of -$8.27 million or -$0.17 per share.

Cash & Cash Equivalents	206,233
Total Debt	8.47M
Net Cash	-8.27M
Net Cash Per Share	-$0.17
Equity (Book Value)	-9.62M
Book Value Per Share	-0.19
Working Capital	-9.57M

Cash Flow

Operating Cash Flow	-2.91M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	88.83%
Shareholder Yield	88.83%
Earnings Yield	-106.50%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2